A detailed history of Marshall Wace, LLP transactions in Embecta Corp. stock. As of the latest transaction made, Marshall Wace, LLP holds 368,035 shares of EMBC stock, worth $7.46 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
368,035
Previous 479,515 23.25%
Holding current value
$7.46 Million
Previous $5.99 Million 13.42%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.46 - $16.56 $1.28 Million - $1.85 Million
-111,480 Reduced 23.25%
368,035 $5.19 Million
Q2 2024

Aug 14, 2024

BUY
$10.13 - $14.6 $639,901 - $922,267
63,169 Added 15.17%
479,515 $5.99 Million
Q1 2024

May 15, 2024

BUY
$12.35 - $19.33 $610,448 - $955,462
49,429 Added 13.47%
416,346 $5.52 Million
Q4 2023

Feb 14, 2024

SELL
$12.87 - $19.09 $1.88 Million - $2.79 Million
-146,232 Reduced 28.5%
366,917 $6.95 Million
Q3 2023

Nov 14, 2023

BUY
$15.0 - $22.17 $7.7 Million - $11.4 Million
513,149 New
513,149 $7.72 Million

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.